The JAK2 V617F have been detected in 46.7 to 100% in patients with PV, from 31.3 to 72.1% in patients with ET, and from 25.0 to 85.7% in those with PMF (data from 2000–2018) [22]. This evidence concerns the gene JAK2 and acquired polycythemia vera.